目次

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Graft Versus Host Disease (GVHD) - Overview
Graft Versus Host Disease (GVHD) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Graft Versus Host Disease (GVHD) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Graft Versus Host Disease (GVHD) - Companies Involved in Therapeutics Development
Graft Versus Host Disease (GVHD) - Drug Profiles
Graft Versus Host Disease (GVHD) - Dormant Projects
Graft Versus Host Disease (GVHD) - Discontinued Products
Graft Versus Host Disease (GVHD) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Graft Versus Host Disease (GVHD), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Graft Versus Host Disease (GVHD) - Pipeline by 9 Meters Biopharma Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Abbisko Cayman Limited, 2022
Graft Versus Host Disease (GVHD) - Pipeline by AbbVie Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Accro BioScience (Suzhou) Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Actitrexx GmbH, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Adienne Pharma & Biotech SA, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Alphamab Oncology, 2022
Graft Versus Host Disease (GVHD) - Pipeline by AltruBio Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Amcyte Pharma Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Amgen Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by AnaMar AB, 2022
Graft Versus Host Disease (GVHD) - Pipeline by AnaptysBio Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by ASC Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by AstraZeneca Plc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Athos Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Autolus Therapeutics Plc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Avalon GloboCare Corp, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Bellicum Pharmaceuticals Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Biocon Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Biogen Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by BioIncept LLC, 2022
Graft Versus Host Disease (GVHD) - Pipeline by BlueRock Therapeutics LLC, 2022
Graft Versus Host Disease (GVHD) - Pipeline by BlueSphere Bio Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Boryung ViGenCell Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Bristol-Myers Squibb Co, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Capricor Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Cellective BioTherapy Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Cellenkos Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Cellestia Biotech AG, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Cellix Bio Pvt Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by CELLnLIFE Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Celltrion Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Cellvation Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by CheckPoint Immunology Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Claritas Pharmaceuticals Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Clinigen Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Connext Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Corvus Pharmaceuticals Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by CSL Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by CTI BioPharma Corp, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Cue Biopharma Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Cynata Therapeutics Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Cytopeutics Pte Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Daewoong Pharmaceutical Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Dianomi Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Dualogics Corp, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Educell doo, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Eli Lilly and Co, 2022
Graft Versus Host Disease (GVHD) - Pipeline by enGene Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Equillium Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by EV Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Evive Biotech, 2022
Graft Versus Host Disease (GVHD) - Pipeline by ExCellThera Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by F. Hoffmann-La Roche Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Fate Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Forte Biosciences Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Genentech USA Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Glia LLC, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Good T Cells Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Grifols SA, 2022
Graft Versus Host Disease (GVHD) - Pipeline by GSK plc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Hangzhou East China Pharmaceutical Group Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Humanigen Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by iCELL Biotechnology Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Immplacate Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Immune Modulation Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by ImmuneTarget Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Imstem Biotechnology Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Incyte Corp, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Inmagene Biopharmaceuticals Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Jazz Pharmaceuticals Plc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by JN Biosciences LLC, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Kadmon Holdings Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Kamada Pharmaceuticals, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Kiniksa Pharmaceuticals Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Kymab Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by MaaT Pharma, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Machavert Pharmaceuticals LLC, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Magenta Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Mallinckrodt Plc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Medexus Pharmaceuticals Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Medicenna Therapeutics Corp, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Mediolanum farmaceutici SpA, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Medsenic SAS, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Merck & Co Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Mereo Biopharma Group Plc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Mesoblast Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Millennium Pharmaceuticals Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by MiNK Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by MitoImmune Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Moderna Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by NapaJen Pharma Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Neoleukin Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Neovii Pharmaceuticals AG, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Nurix Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by OncoC4 Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Orca Biosystems Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by OSE Immunotherapeutics SA, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Ossium Health Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Panorama Researchama Research, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Pfizer Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Platinum Biotech (Beijing) Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Pluristem Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Precision Biosciences Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Rebus Holdings Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by REGiMMUNE Corp, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Rheos Medicines Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Sanofi, 2022
Graft Versus Host Disease (GVHD) - Pipeline by SCM lifescience Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Seagen Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Secura Bio Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Seres Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Shenzhen Chipscreen Biosciences Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Sino Biopharmaceutical Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Sorrento Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by STERO Biotechs Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by StingInn LLC, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Suzhou Connect Biopharmaceuticals Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Suzhou Regend Therapeutics Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Suzhou Zelgen Biopharmaceutical Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Syndax Pharmaceuticals Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Synthetic Biologics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Takeda Pharmaceutical Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Targazyme Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by TCF GmbH, 2022
Graft Versus Host Disease (GVHD) - Pipeline by TCR2 Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by TeraImmune Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Tianjin Angsai Cell Genetic Engineering Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by TreeFrog Therapeutics SAS, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Triursus Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by United BioPharma Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Vault Pharma Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by VectivBio Holding AG, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Vedanta Biosciences Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Viracta Therapeutics Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Visterra Inc, 2022
Graft Versus Host Disease (GVHD) - Pipeline by VITRAC Therapeutics LLC, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Xbiome Co Ltd, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Xenikos BV, 2022
Graft Versus Host Disease (GVHD) - Pipeline by Xenothera SAS, 2022
Graft Versus Host Disease (GVHD) - Dormant Projects, 2022
Graft Versus Host Disease (GVHD) - Discontinued Products, 2022

List of Figures
Number of Products under Development for Graft Versus Host Disease (GVHD), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022